Revision der Klassifikation somatoformer Störungen

Als Konsequenz der umfassenden Kritik an der Klassifikation somatoformer Störungen und insbesondere der Somatisierungsstörung nach dem DSM-IV und der ICD-10 wurde diese Diagnosekategorie mit Erscheinen des DSM-5 grundlegend revidiert und die neue zentrale Diagnose Somatische Belastungsstörung eingef...

Ausführliche Beschreibung

Gespeichert in:
1. Verfasser: Klaus-Schiffer, Kristina
Beteiligte: Rief, Winfried (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Format: Dissertation
Veröffentlicht: Philipps-Universität Marburg 2015
Online Zugang:PDF-Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

1. Cedraschi C, Girard E, Luthy C, Kossovsky M, Desmeules J, Allaz A-F. Primary attributions in women suffering fibromyalgia emphasize the perception of a disruptive onset for a long-lasting pain problem. J Psychosom Res 2013;74:265-269.

2. Chen AT. Information seeking over the course of illness: the experience of people with fibromyalgia. Musculoskeletal Care 2012;10:212-220.

3. Hazlett RL, Haynes SN. Fibromyalgia: a time-series analysis of the stressor-physical symptom association. J Behav Med 1992;15:541-558.

4. Offenbaecher M, Waltz M, Schoeps P. Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 2000;27:1984-1988.

5. Häuser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome -a systematic review. Eur J Pain 2010;14:5-10.

6. Kroenke K, Spitzer RL, Williams JB, Loewe B. The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010;32:345-359.

7. Fink P, Schröder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 2010;68:415-426.

8. Karsdorp PA, Vlaeyen JWS. Active avoidance but not activity pacing is associated with disability in fibromyalgia. Pain 2009;147:29-35.

9. Kroenke K. Somatoform disorders and recent diagnostic controversies. Psychiatr Clin North Am 2007;30:593-619.

10. Maas CJM, Hox JJ. Sufficient sample sizes for multilevel modeling. Eur J Res Method Behav Soc Sci 2005;1:86-92.

11. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol 2006;35:468-476.

12. McBeth J, Macfarlane GJ, Hunt IM, Silman AJ. Risk factors for persistent chronic widespread pain: a community-based study. Rheumatology (Oxford) 2001;40:95-101.

13. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258-266.

14. Warren JW, Clauw DJ. Functional somatic syndromes: sensitivities and specificities of self-reports of physician diagnosis. Psychosom Med 2012;74:891-895.

15. Berger A, Sadosky A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin 2008;24:2489-2499.

16. Sanchez RJ, Uribe C, Li H, Alvir J, Deminski M, Chandran A, Palacio A. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin 2011;27:663-671.

17. Robbins JM, Kirmayer LJ, Kapusta MA. Illness worry and disability in fibromyalgia syndrome. Int J Psychiat Med 1990;20:49-63.

18. Fahrenberg J, Myrtek M, Pawlik K, Perrez M. Ambulatory assessment -monitoring behavior in daily life settings. Eur J Psychol Assess 2007;23:206-213.

19. Ebner-Priemer UW, Trull TJ. Ambulatory assessment: an innovative and promising approach for clinical psychology. Eur Psychol 2009;14:109-119.

20. Aguglia A, Salvi V, Maina G, Rossetto I, Aguglia E. Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates. J Affect Disorders 2011;128:262-266.

21. Brosschot JF, Aarsse HR. Restricted emotional processing and somatic attribution in fibromyalgia. Int J Psychiat Med 2001;31:127-146.

22. Sánchez AI, Martínez MP, Miró E, Medina A. Predictors of the pain perception and self- efficacy for pain control in patients with fibromyalgia. Span J Psychol 2011;14:366- 373.

23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (5th ed.; DSM-5). Arlingten, VA: American Psychiatric Association, 2013.

24. Häuser W, Burgmer M, Köllner V, Schaefert R, Eich W, Hausteiner-Wiehle C, Henningsen P. [Fibromyalgia syndrome as a psychosomatic disorder -diagnosis and therapy according to current evidence-based guidelines]. Z Psychosom Med Psychother 2013;59:132-152.

25. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999;354:936-939.

26. Muller A, Hartmann M, Eich W. [Health care utilization in patients with fibromyalgia syndrome (FMS)]. Schmerz 2000;14:77-83.





31. Häuser W, Zimmer C, Felde E, Köllner V. [What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association]. Schmerz 2008;22:176- 183.

32. Häuser W, Schild S, Kosseva M, Hayo S, von Wilmowski H, Alten R, Langhorst J, Hofmann W, Maus J, Glaesmer H. [Validation of the German version of the Regional Pain Scale for the diagnosis of fibromyalgia syndrome]. Schmerz 2010;24:226-235.

33. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011;38:1113-1122.

34. Wolfe F, Braehler E, Hinz A, Haeuser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthrit Care Res 2013;65:777-785.

35. Häuser W, Henningsen P. Fibromyalgia syndrome: a somatoform disorder? Eur J Pain 2014;18:1052-1059.

36. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007;369:946-955.

37. Fink P, Rosendal M, Olesen F. Classification of somatization and functional somatic symptoms in primary care. Aust N Z J Psychiatry 2005;39:772-781.

38. Van Wilgen CP, van Ittersum MW, Kaptein AA, van Wijhe M. Illness perceptions in patients with fibromyalgia and their relationship to quality of life and catastrophizing. Arthritis Rheum 2008;58:3618-3626.

39. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613.

40. Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 2008;62:115-126.

41. Browning M, Fletcher P, Sharpe M. Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom Med 2011;73:173- 184.

42. Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, Langhorst J, Weiss T, Winkelmann A, Wolfe F. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One 2012;7:e37504. APPENDIX Dissertation K. Klaus-Schiffer · Marburg · 2014

43. Sansone RA, Levengood JV, Sellbom M. Psychological aspects of fibromyalgia: research vs. clinician impressions. J Psychosom Res 2004;56:185-188.

44. Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, Kuck J, Leslie V, Masur D, Wagner M, Waid R, Zisook S. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999;40:57-63.

45. Nicholl BI, Macfarlane GJ, Davies KA, Morriss R, Dickens C, McBeth J. Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread pain -results from the EPIFUND study. Pain 2009;141:119-126.

46. Tuzer V, Bulut SD, Bastug B, Kayalar G, Goka E, Bestepe E. Causal attributions and alexithymia in female patients with fibromyalgia or chronic low back pain. Nord J Psychiat 2011;65:138-144.

47. Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res 2013;5:171-180.